Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats

Journal of Hypertension

Volumn 21, Issue 10, 2003, Pages 1961-1967

  Liu, Jian Guo ^a   Xu, Li Ping ^a   Chu, Zheng Xu ^a   Miao, Chao Yu ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; Blood pressure variability; End organ damage; Hydralazine; Hypertension; Nitrendipine; Spontaneously hypertensive rat

Indexed keywords

HYDRALAZINE; NITRENDIPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART INJURY; HYPERTENSION; KIDNEY INJURY; LONG TERM CARE; MALE; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0142010506     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200310000-00025     Document Type: Article

References (29)

1. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53:96-104.
2. Su DF, Cerutti C, Barres C, Vincent M, Sassard J. Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am J Physiol 1986; 251:H1111-1117.
3. Miao CY, Shen FM, Su DF. Blood pressure variability is increased in genetic hypertension and L-NAME-induced hypertension. Acta Pharmacol Sin 2001; 22:137-140.
4. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 1987; 5:93-98.
5. Mancia G, Frattola A, Parati G, Santucciu C, Ulian L. Blood pressure variability and organ damage. J Cardiovasc Pharmacol 1994; 24(suppl A):S6-S11.
6. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 2001; 28:709-715.
7. Shan ZZ, Dai SM, Su DF. Relationship between baroreceptor reflex function and end-organ damage in spontaneously hypertensive rats. Am J Physiol 1999; 277:H1200-H1206.
8. Su DF, Chen L, Kong XB, Cheng Y. Determination of arterial baroreflex-blood pressure control in conscious rats. Acta Pharmacol Sin 2002; 23:103-109.
9. Su DF, Cerutti C, Barres C, Julien C, Vincent M, Paultre C, Sassard J. Arterial baroreflex control of heart period is not related to blood pressure variability in conscious hypertensive and normotensive rats. Clin Exp Pharmacol Physiol 1992; 19:767-775.
10. Notoya M, Nakamura M, Mizojiri K. Effects of lisinopril on the structure of renal arterioles. Hypertension 1996; 27:364-370.
11. Higashi T, Kobayashi N, Hara K, Shirataki H, Matsuoka H. Effects of angiotensin II type 1 receptor antagonist on nitric oxide synthase expression and myocardial remodeling in Goldblatt hypertensive rats. J Cardiovasc Pharmacol 2000; 35:564-571.
12. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24 hour blood pressure variability. J Hypertens 1993; 11:1133-1137.
13. Kikuya M, Hozawa A, Ohokubo T, Tsuji I, Michmata M, Matsubara M, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000; 36:901-906.
14. Sander D, Kukla C, Klingelhofer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000; 102:1536-1541.
15. Miao CY, Tao X, Gong K, Zhang SH, Chu ZX, Su DF. Aterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol 2001; 37:6-15.
16. Shan ZZ, Dai SM, Su DF. Arterial baroreflex deficit induced organ damage in sinoaortic denervated rats. J Cardiovas Pharmacol 2001; 38:427-437.
17. Su DF, Miao CY. Arterial baroreflex function in conscious rats. Acta Pharmacol Sin 2002; 23:673-679.
18. Miao CY, Su DF. The importance of blood pressure variability in rat aortic and ventricular hypertrophy produced by sinoaortic denervation. J Hypertens 2002; 20:1865-1872.
19. Parati G, Lantelme P. Blood pressure variability, target organ damage and cardiovascular events. J Hypertens 2002; 20:1725-1729.
20. Sasaki S, Yoneda Y, Fujita H, Uchida A, Takenaka K, Takesako T, et al. Association of blood pressure variability with induction of atherosclerosis in cholesterol-fed rats. Am J Hypertens 1994; 7:453-459.
21. Miao CY, Xie HH, Yu H, Chu ZX, Su DF. Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003; 30:189-193.
22. 2A-receptor. J Cardiovasc Pharmacol 2000; 36:681-686.
23. Jacob HJ, Alper RH, Brody J. Lability of arterial pressure after baroreceptor denervation is not pressure dependent. Hypertension 1989; 14: 501-510.
24. Du WM, Miao CY, Liu JG, Shen FM, Yang XQ, Su DF. Effects of long-term treatment with ketanserin on blood pressure variability and end-organ damage in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003; 41:233-239.
25. Lu ZA, Xie HH, Xu LP, Yin AF, Miao CY, Su DF. Restoration of arterial baroreflex function contributes to organ protection in spontaneously hypertensive rats treated with hydrochlorothiazide mixture. Clin Exp Pharmacol Physiol 2002; 30:49-54.
26. Miao CY, Xie HH, Wang JJ, Su DF. Candesartan inhibits sinoaortic denervation- induced cardiovascular hypertrophy in rats. Acta Phamacol Sin 2002; 23:713-720.
27. Lefrandt JD, Heitmann J, Sevre K, Castellano M, Hausberg M, Fallon M, et al. The effects of dihydropyridine and phenylalkylamine calcium antagonist classes on autonomic function in hypertension: the VAMPHYRE study. Am J Hypertens 2001; 14:1083-1089.
28. Staessen JA, Asmar R, De Buyzere M, Imai Y, Parati G, Shimada K, et al. Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit 2001; 6:355-370.
29. Jokiniity JM, Majahalme SK, Kahonen MA, Tuomisto MT, Turjanmaa VM. Prediction of blood pressure level and need for antihypertensive medication: 10 years of follow-up. J Hypertens 2001; 19:1193-1201.